Fonar Corporation - Asset Resilience Ratio
Fonar Corporation (FONR) has an Asset Resilience Ratio of 0.06% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read FONR current and long-term liabilities for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (1987–2025)
This chart shows how Fonar Corporation's Asset Resilience Ratio has changed over time. See Fonar Corporation shareholders equity for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Fonar Corporation's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see FONR market cap.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $121.00K | 0.06% |
| Total Liquid Assets | $121.00K | 0.06% |
Asset Resilience Insights
- Limited Liquidity: Fonar Corporation maintains only 0.06% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Fonar Corporation Industry Peers by Asset Resilience Ratio
Compare Fonar Corporation's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Sonic Healthcare Ltd
AU:SHL |
Diagnostics & Research | 0.13% |
|
Eurofins-Cerep SA
PA:ALECR |
Diagnostics & Research | 6.56% |
|
Inoviq Ltd
AU:IIQ |
Diagnostics & Research | 56.29% |
|
Bcal Diagnostics Ltd
AU:BDX |
Diagnostics & Research | 0.00% |
|
Imagion Biosystems Ltd
AU:IBX |
Diagnostics & Research | 150.16% |
|
Integral Diagnostics Ltd
AU:IDX |
Diagnostics & Research | 0.03% |
|
Australian Clinical Labs Ltd
AU:ACL |
Diagnostics & Research | 4.11% |
|
Monash Ivf Group Ltd
AU:MVF |
Diagnostics & Research | 1.60% |
Annual Asset Resilience Ratio for Fonar Corporation (1987–2025)
The table below shows the annual Asset Resilience Ratio data for Fonar Corporation.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-06-30 | 0.06% | $120.49K | $216.91 Million | -0.01pp |
| 2024-06-30 | 0.06% | $136.10K | $214.25 Million | +0.05pp |
| 2023-06-30 | 0.02% | $32.80K | $200.58 Million | +0.00pp |
| 2022-06-30 | 0.02% | $32.33K | $199.34 Million | 0.00pp |
| 2021-06-30 | 0.02% | $32.18K | $189.51 Million | 0.00pp |
| 2020-06-30 | 0.02% | $31.88K | $180.26 Million | -11.28pp |
| 2019-06-30 | 11.30% | $15.09 Million | $133.56 Million | -- |
| 2018-06-30 | 0.00% | $0.00 | $118.31 Million | -- |
| 2017-06-30 | 0.00% | $0.00 | $98.76 Million | -- |
| 2016-06-30 | 0.00% | $0.00 | $84.89 Million | -- |
| 2015-06-30 | 0.00% | $0.00 | $76.49 Million | -- |
| 2014-06-30 | 0.00% | $0.00 | $76.79 Million | -- |
| 2013-06-30 | 0.00% | $0.00 | $73.15 Million | -- |
| 2011-06-30 | 0.10% | $32.53K | $31.58 Million | -0.02pp |
| 2010-06-30 | 0.13% | $27.61K | $21.63 Million | +0.05pp |
| 2009-06-30 | 0.08% | $22.65K | $28.36 Million | -2.95pp |
| 2008-06-30 | 3.03% | $1.07 Million | $35.23 Million | -1.77pp |
| 2007-06-30 | 4.80% | $1.98 Million | $41.21 Million | -3.83pp |
| 2006-06-30 | 8.63% | $4.94 Million | $57.23 Million | -3.74pp |
| 2005-06-30 | 12.37% | $9.41 Million | $76.09 Million | -2.04pp |
| 2004-06-30 | 14.40% | $11.12 Million | $77.20 Million | +4.47pp |
| 2003-06-30 | 9.94% | $5.84 Million | $58.75 Million | +2.28pp |
| 2002-06-30 | 7.65% | $5.57 Million | $72.83 Million | +0.51pp |
| 2001-06-30 | 7.15% | $6.09 Million | $85.16 Million | -6.43pp |
| 2000-06-30 | 13.57% | $11.48 Million | $84.60 Million | -7.12pp |
| 1999-06-30 | 20.70% | $20.20 Million | $97.60 Million | +18.19pp |
| 1988-06-30 | 2.51% | $1.10 Million | $43.90 Million | +0.50pp |
| 1987-06-30 | 2.01% | $700.00K | $34.90 Million | -- |
About Fonar Corporation
FONAR Corporation, together with its subsidiaries, engages in the designing, manufacturing, selling, and servicing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases, abnormalities, other medical conditions, and injuries in the United States. It operates in two segments: Medical Equipment, and Physician Management and Diagnostic Services. The company of… Read more